Regular articleAdriamycin enhanced in vitro and in vivo photodynamic therapy of mesothelioma
References (13)
- et al.
Benign and malignant pleural mesothelioma
Clin. Chest Med.
(1985) - et al.
Pleural mesothelioma
Ann. Thorac. Surg.
(1987) - et al.
Multimodality therapy for malignant mesothelioma based on a study of natural history
Am. J. Med.
(1980) - et al.
In vitro killing of human malignant mesothelioma by photodynamic therapy
J. Surg. Res.
(1990) - et al.
Photodynamic therapy for human malignant mesothelioma in the nude mouse
J. Surg. Res.
(1990) - et al.
Potentiation of photodynamic therapy with hematoporphyrin derivatives by glucocorticoids
Cancer Lett.
(1985)
There are more references available in the full text version of this article.
Cited by (18)
Enhanced antitumor activity of combinations of free and HPMA copolymer-bound drugs
2008, International Journal of PharmaceuticsSelenite induces apoptosis in sarcomatoid malignant mesothelioma cells through oxidative stress
2006, Free Radical Biology and MedicineCombined effect of low-power laser irradiation and anthraquinone anticancer drug aclarubicin on survival of immortalized cells: Comparison with mitoxantrone
2006, Cell Biology InternationalCitation Excerpt :To compare the efficacy in photosensitizing cell killing of aclarubicin with that of mitoxantrone we measured photosensitizing effects that take a relatively long time to develop—the inhibition of cell proliferation and long-term cytotoxicity. Many groups reported quantitative differences in the long-term cytotoxic effects among anthracyclines (Andreoni et al., 1991a,b,c; Brophy and Keller, 1992; Gao et al., 1997; Lanks et al., 1994; Paiva et al., 1996). The enhancement in drug potency, however, was shown to depend on the cell line (Gao et al., 1997).
Effects of photodynamic therapy in combination with Adriamycin
1999, Cancer Letters
Copyright © 1992 Published by Elsevier Inc.